Jersey
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 509.34 M
|
Dec. 31, 2023 | USD 24.52 | -3.88% |
|
Jersey |
The Clinical Trials company in Jersey with the highest Revenue is NovoCure Limited (NasdaqGS: NVCR) at USD 509.34 M.
The Clinical Trials company in Jersey with the lowest Revenue is NovoCure Limited (NasdaqGS: NVCR) at USD 509.34 M.
The top 10 Clinical Trials companies in Jersey by Revenue are and NovoCure Limited.
The bottom 10 Clinical Trials companies in Jersey by Revenue are and NovoCure Limited.